SCHEMBL15575979

SCHEMBL15575979

Nc1ccccc1NC[C@H]1CCCN1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 6/20 0.43
TDO2 P48775 6/20 0.43
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
POLB P06746 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.40
LTA4H P09960 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
HTR6 P50406 2/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
MAPK3 P27361 1/20 0.38
MAPK1 P28482 1/20 0.38
SYK P43405 1/20 0.38
KCNH2 Q12809 1/20 0.38
AURKB Q96GD4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2202298 0.81 HTR2A (0.44) IDO1TDO2POLBIRAK4
SCHEMBL2202303 0.81 HTR2A (0.44) IDO1TDO2POLBIRAK4
SCHEMBL10839238 0.79 IDO1 (0.44) IDO1TDO2IRAK4HTR6
SCHEMBL10906269 0.78 CHRNB4 (0.59) MAPTCHRNB4CHRNA3
SCHEMBL10906268 0.78 CHRNB4 (0.59) MAPTCHRNB4CHRNA3
SCHEMBL1116568 0.77 LTA4H (0.52) POLBIRAK4LTA4HCHRNB4CHRNA3
SCHEMBL3329262 0.77 LTA4H (0.52) POLBIRAK4LTA4HCHRNB4CHRNA3
SCHEMBL1116569 0.77 LTA4H (0.52) POLBIRAK4LTA4HCHRNB4CHRNA3
SCHEMBL20837293 0.75 MAPT (0.53) KDM4EGAAMAPTHDAC3HDAC1
SCHEMBL977627 0.74 PTGER4 (0.47) KDM4EGAAMAPTHDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2890691-A1 BENZIMIDAZOLE DERIVATIVES AS ITK INHIBITORS Principia Biopharma Inc. (US) 2015-07-08 EP disclosed
WO-2014036016-A1 BENZIMIDAZOLE DERIVATIVES AS ITK INHIBITORS PRINCIPIA BIOPHARMA INC. (US) 2014-03-06 WO disclosed